The Annual General Meeting authorized the Board of Directors to decide on share issue, carried out with or without
payment and on issuing share options, and other special rights referred to in Chapter 10, Section1 of the Finnish
Companies Act as follows:
The maximum total amount of shares or other rights is 3,000,000. The authorization includes the right to give new
shares and special rights or convey the company’s own shares. The authorization includes the right to deviate from the
shareholders’ pre-emptive right of subscription if there is a weighty financial reason for the company, e.g., to improve
the capital structure, to execute of business acquisitions and other business improvement arrangements. The
authorization cannot be used to implement the company’s incentive schemes. The authorization includes the right for
the Board of Directors to decide on the other terms concerning the share issue and the granting of special rights,
including the subscription price and payment of the subscription price in cash or in whole or in part by other means
(subscription in kind) or by using a claim on the subscriber to offset the subscription price and to record it in the
company's balance sheet. The authorization is effective until the next annual general meeting, however, no longer than
until April 30, 2023 (April 30, 2023 included).
The Annual General Meeting authorized the Board of Directors to decide on share issue, carried out with or without
payment and on issuing share options, and other special rights referred to in Chapter 10, Section1 of the Finnish
Companies Act as part of the implementation of the company’s incentive schemes as follows:
The maximum total amount of shares or other rights is 1,000,000. The authorization includes the right to give new
shares and special rights or convey the company’s own shares. The authorization includes the right to deviate from the
shareholders’ pre-emptive right of subscription as part of the implementation of the company’s incentive schemes, in
which case there is a weighty financial reason for the company. The authorization includes the right for the Board of
Directors to decide on the other terms concerning the share issue and the granting of special rights, including the
subscription price and payment of the subscription price in cash or by using a claim on the subscriber to offset the
subscription price and to record it in the company's balance sheet. The authorization is effective until the next annual
general meeting, however, no longer than until April 30, 2023 (April 30, 2023, included).
The Annual General Meeting authorized the Board of Directors to decide on repurchasing of the company’s own shares
as follows:
On the basis of the authorization the number of own shares to be repurchased shall not exceed 500,000 shares. Shares
may be repurchased in one or more lots. The Company may use only unrestricted equity to repurchase own shares.
Repurchase of own shares may be made otherwise than in proportion to the share ownership of the shareholders
(directed repurchase). The purchase price shall be at least the lowest price paid for the company’s shares in regulated
trading at the time of purchase and no more than the highest price paid for Company shares in regulated trading at the
time of purchase. Own shares can be purchased to be used to improve the capital structure of the company, to execute
of business acquisitions and other business improvement arrangements or as a part of the implementation the
company’s incentive schemes. The authorization is effective until the next annual general meeting, however, no longer
than until April 30, 2023 (April 30, 2023, included).
In addition, the Annual General Meeting authorized the Board of Directors to decide on accepting the company’s own
shares as pledge as follows:
The Board of Directors is authorized to decide on accepting the company’s own shares as pledge (directed) regarding
business acquisitions or when executing other business arrangements. Accepting pledge may occur at once or in
multiple transactions. The number of own shares to be accepted as pledge shall not exceed 2,000,000 shares. The
authorization includes that the Board of Directors may decide on all other terms concerning the accepting as pledge.